ICAM1 and Alzheimer disease: Studies in humans revealed that the Icam1 gene product was increased in the cerebrospinal fluid (CSF) in preclinical, prodromal, and dementia stages of AD, associated with cortical thinning and cognitive deterioration and could act as a biomarker for early neuroinflammation and an AD risk assessment factor [142].